Intragenic recombination in the 3' portion of the merozoite surface protein 1 gene of Plasmodium vivax

Molecular and Biochemical Parasitology

Volumn 109, Issue 2, 2000, Pages 111-119

  Putaporntip, Chaturong ^a   Jongwutiwes, Somchai ^a   Seethamchai, Sunee ^b   Kanbara, Hiroji ^c   Tanabe, Kazuyuki ^d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

^c NAGASAKI UNIVERSITY   (Japan)

^d OSAKA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Malaria; Merozoite surface protein 1; Plasmodium vivax; Recombination; Sequence

Indexed keywords

MEROZOITE SURFACE PROTEIN 1;

ALLELE; ARTICLE; GENE SEQUENCE; GENETIC RECOMBINATION; GENETIC VARIABILITY; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL;

3' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CONSERVED SEQUENCE; HUMANS; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 0033848080     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(00)00238-3     Document Type: Article

References (26)

1. Wernsdorfer W.H. The development and spread of drug-resistant malaria. Parasitol. Today. 7:1991;297-303.
2. Holder A.A. The precursor to major merozoite surface antigens: structure and role in immunity. Prog. Allergy. 41:1988;72-97.
3. Holder A.A., Riley E.M. Human immune response to MSP-1. Parasitol. Today. 12:1996;173-174.
4. Tanabe K., Mackay M., Goman M., Scaife J.G. Allelic dimorphism in a surface antigen gene of malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:1987;273-287.
5. Kerr P.J., Ranford-Cartwright L.C., Walliker D. Proof of intragenic recombination in Plasmodium falciprum. Mol. Biochem. Parasitol. 66:1994;241-248.
6. Udagama P.V., Gamage-Mendis A.C., David P.H. et al. Genetic complexity of Plasmodium vivax parasites in individual human infections analyzed with monoclonal antibodies against variant epitopes on a single parasite protein. Am. J. Trop. Med. Hyg. 42:1990;104-110.
7. Mertens F., Levitus G., Ferreira M.U., Camargo L.M.A., Dutra A.P., del Portillo H.A. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil. Am. J. Trop. Med. Hyg. 49:1993;383-392.
8. Mancilla L.I., Levitus G., Kirchgatter K., Mertens F., Herrera S., del Portillo H.A. Plasmodium vivax: dimorphic DNA sequences from the MSP-1 gene code for regions that are immunogenic in natural infections. Exp. Parasitol. 79:1994;148-158.
9. Soares I.S., Oliveira S.G., Souza J.M., Rodrigues M.M. Antibody response to the N- and C-terminal regions of the Plasmodium vivax merozoite surface protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil. Acta Trop. 72:1999;13-24.
10. Yang C., Collins W.E., Sullivan J.S., Kaslow D.C., Xiao L., Lal A.A. Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant. Infect. Immun. 67:1999;342-349.
11. Valero L.M.S., Ogun S.A., Fluk S.L. et al. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia. Infect. Immun. 66:1998;3925-3930.
12. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc. Natl. Acad. Sci. USA. 88:1991;4030-4034.
13. Gibson H.L., Tucker J.E., Kaslow D.C. et al. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 50:1992;325-334.
14. Cheng Q., Stowers A., Huang T.Y. et al. Polymorphism in Plasmodium vivax MSA1 gene-the result of intragenic recombination? Parasitology. 106:1993;335-345.
15. Putaporntip C., Jongwutiwes S., Tanabe K., Thaithong S. Interallelic recombination in the merozoite surface protein 1 (MSP-1) gene of Plasmodium vivax from Thai isolates. Mol. Biochem. Parasitol. 84:1997;49-56.
16. Pasay M.C., Cheng Q., Rzepczyk C., Saul A. Dimorphism of the C-terminus of the Plasmodium vivax merozoite surface protein 1. Mol. Biochem. Parasitol. 70:1995;217-219.
17. Soares I.S., Barnwell J.W., Ferreira M.U. et al. A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol. Med. 5:1999;459-470.
18. Kolakovich K.A., Ssengoba A., Wojcik K. et al. Plasmodium vivax: favored gene frequencies of the merozoite surface protein-1 and the multiplicity of infection in a malaria endemic region. Exp. Parasitol. 83:1996;11-18.
19. Jongwutiwes S., Tanabe K., Kanbara H. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 59:1993;95-100.
20. Sakihama N., Kimura M., Hirayama K. et al. Allelic recombination and linkage disequilibrium within MSP-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene. 230:1999;47-54.
21. Egan A., Waterfall M., Pinder M., Holder A., Riley E. Characterization of human T- and B-cell epitopes in the C-terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect. Immun. 65:1997;3024-3031.
22. Hughes A.L. Circumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regions. Genetics. 127:1991;345-353.
23. Jongwutiwes S., Tanabe K., Hughes M.K., Kanbara H., Hughes A.L. Allelic variation in the circumsporozoite protein of Plasmodium falciparum from Thai field isolates. Am. J. Trop. Med. Hyg. 51:1994;659-668.
24. Qari S.H., Shi Y.P., Goldman I.F., Nahlen B.L., Tibayrenc M., Lal A.A. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol. 92:1998;241-252.
25. Riley E.M., Allen S.J., Wheeler J.G. et al. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:1992;321-337.
26. Egan A., Morris J., Barnish G. et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibody to the 19 kDa C-terminal fragment of the merozoite surface antigen, PfMSP1. J. Infect. Dis. 173:1996;765-769.